Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1957 1
1959 1
1960 1
1963 2
1964 1
1967 1
1968 2
1969 2
1971 1
1976 1
1977 2
1978 6
1979 3
1980 2
1981 4
1982 6
1983 3
1984 3
1985 2
1986 9
1987 4
1988 9
1989 6
1990 7
1991 5
1993 5
1994 5
1995 7
1996 3
1997 14
1998 12
1999 10
2000 15
2001 30
2002 10
2003 13
2004 14
2005 7
2006 12
2007 14
2008 13
2009 13
2010 15
2011 16
2012 18
2013 16
2014 19
2015 27
2016 18
2017 19
2018 18
2019 11
2020 24
2021 20
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

462 results
Results by year
Filters applied: . Clear all
Page 1
Management of acromioclavicular joint injuries.
Stucken C, Cohen SB. Stucken C, et al. Among authors: cohen sb. Orthop Clin North Am. 2015 Jan;46(1):57-66. doi: 10.1016/j.ocl.2014.09.003. Epub 2014 Oct 11. Orthop Clin North Am. 2015. PMID: 25435035 Review.
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis.
Plumlee CR, Duffy FJ, Gern BH, Delahaye JL, Cohen SB, Stoltzfus CR, Rustad TR, Hansen SG, Axthelm MK, Picker LJ, Aitchison JD, Sherman DR, Ganusov VV, Gerner MY, Zak DE, Urdahl KB. Plumlee CR, et al. Among authors: cohen sb. Cell Host Microbe. 2021 Jan 13;29(1):68-82.e5. doi: 10.1016/j.chom.2020.10.003. Epub 2020 Nov 2. Cell Host Microbe. 2021. PMID: 33142108 Free PMC article.
Leflunomide.
Cohen SB, Iqbal I. Cohen SB, et al. Int J Clin Pract. 2003 Mar;57(2):115-20. Int J Clin Pract. 2003. PMID: 12661795 Review.
Phobias.
Cohen SB. Cohen SB. Am J Clin Hypn. 1981 Apr;23(4):227-30. doi: 10.1080/00029157.1981.10404026. Am J Clin Hypn. 1981. PMID: 7282574 No abstract available.
Malignancy and Janus Kinase Inhibition.
Sivaraman P, Cohen SB. Sivaraman P, et al. Among authors: cohen sb. Rheum Dis Clin North Am. 2017 Feb;43(1):79-93. doi: 10.1016/j.rdc.2016.09.008. Rheum Dis Clin North Am. 2017. PMID: 27890175 Review.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Free article. Clinical Trial.
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT. Breedveld FC, et al. Among authors: cohen sb. Arthritis Rheum. 2006 Jan;54(1):26-37. doi: 10.1002/art.21519. Arthritis Rheum. 2006. PMID: 16385520 Free article. Clinical Trial.
462 results